CRIS Connect: Accelerating Clinical Innovations into Market

Registration

Please register via https://for.sg/crisconnect
Registration closes Mon, 28 Jul 2025.

About the Speakers

Dr Aishwarya Bandla
Clinical Innovation Manager, Paxman Coolers Ltd

Dr Aishwarya Bandla holds a Ph.D. in Biomedical Engineering from the National University of Singapore (NUS). Her research specialises in wearable technology for cancer care. At Paxman Coolers Ltd., she leads the development of a wearable limb cryocompression device to prevent chemotherapy-induced peripheral neuropathy.

She also serves as an Adjunct Senior Research Fellow and Principal Investigator at the N.1 Institute for Health, NUS as well as the Vice Chair of the Insitute of Electrical and Electronics Engineers (IEEE) Singapore Section.

Dr Bandla is a recipient of multiple awards, including Outstanding Mentor by the Singapore Medical Association Charity Fund and named Singapore's 100 Women in Tech in 2020.

Dr Rachel Wong Su Jen
Consultant (Medical Oncology), National University Cancer Institute, Singapore (NCIS), National University Health System (NUHS)

Dr Rachel Wong Su Jen is a Medical Oncology Consultant at NCIS. Her clinical and research interest is in breast cancer, with a special focus on cancer supportive care and the use of digital health to improve patient care and healthcare delivery.

She is the Primary Investigator of the clinical trial evaluating the use of a wearable limb cryocompression device to prevent chemotherapy-induced peripheral neuropathy.

Ms Smitha Velayil

Manager (Innovation & Enterprise), National Health Innovation Centre Singapore (NHIC), Consortium for Clinical Research and Innovation, Singapore (CRIS)

Ms Smitha Velayil holds a dual Masters degree in Biotechnology and Business Administration (MSc-MBA). In her current role at NHIC, she manages biomedical technology projects from the public healthcare institutes towards commercialisation.

She started her career as a clinical research coordinator in the field of infectious diseases before moving on to business development and programme management roles associated with biofilms and microbiomes, innovative and interdisciplinary big data projects, university-level strategic biomedical cluster among others.